|
| Monday | MO-I345-GePD-F5-1 : Can 0.345T Magnetic Resonance Images Be Used in Breast Cancer for Post Lumpectomy Target Delineation?
P.Yadav*, H.Musunuru, J.Witt, A.Kuczmarska-Haas, B.Anderson, F.Kelcz,
P.Mahler |
|
| Monday | MO-I345-GePD-F5-2 : Evaluation of the Clinical Impact of Dark Current On the Delivery of Gated Treatments with An MR-Guided Radiotherapy System
A.Shepard*, K.Mittauer, J.Bayouth, P.Yadav |
|
| Monday | MO-I345-GePD-F5-3 : Implementing Absolute Dose Measurements On SunNuclear ArcCHECK-MR in a 0.35T MR-Linac
A.Price*, A.Heermann, B.Maraghechi, A.Curcuru, V.Rodriguez, S.Mutic,
O.Green |
|
| Monday | MO-I345-GePD-F5-4 : Secondary MU Check Using RadCalc for Elekta Unity MR-Linac
J.Yang*, S.Vedam, C.Brink, M.Nielsen, M.Ji, L.Bist,
J.Ohrt, J.Wang, P.Balter |
|
| Monday | MO-I345-GePD-F5-5 : The ERE of Photon Beams Under Transverse Magnetic Resonance Imaging (MRI) Field Strengths
R.Lambo*, Y.Wang |
|
| Monday | MO-I345-GePD-F5-6 : MR Guided Stereotactic Body Radiation Therapy with Simultaneous Integrated Boost to Dominant Intraprostatic Lesions for Prostate Cancer: A Retrospective Dosimetric Study
D.Du*, J.Lee, M.Pantelic, N.Hurst, B.Movsas, I.Chetty,
N.Wen |
